1. Home
  2. NXGL vs SPRC Comparison

NXGL vs SPRC Comparison

Compare NXGL & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexGel Inc

NXGL

NexGel Inc

HOLD

Current Price

$0.18

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

N/A

Current Price

$5.23

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXGL
SPRC
Founded
1997
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
3.3M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
NXGL
SPRC
Price
$0.18
$5.23
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $2.00
N/A
AVG Volume (30 Days)
★ 138.0K
23.3K
Earning Date
05-11-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.00
N/A
EPS
N/A
★ N/A
Revenue
★ $11,421,000.00
N/A
Revenue This Year
$50.77
N/A
Revenue Next Year
$46.15
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 31.46
N/A
52 Week Low
$0.24
$0.46
52 Week High
$2.89
$15.79

Technical Indicators

Market Signals
Indicator
NXGL
SPRC
Relative Strength Index (RSI) 25.63 47.21
Support Level N/A $4.31
Resistance Level $0.38 $6.24
Average True Range (ATR) 0.03 0.37
MACD -0.00 0.07
Stochastic Oscillator 16.72 68.60

Price Performance

Historical Comparison
NXGL
SPRC

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: